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Endothelium serves as the cellular barrier retaining blood components within the
intravascular space(1). Thisfunction iscompromisedin many pathophysiologic states.
Most notably, the profound alterations inendothelial cellbarrierfunction specifically
induced by host mediators released in response to bacterial LPS contribute impor-
tantly to the pathogenesis of endotoxic/septic shock.
The cytokine tumor necrosis factor/cachectin (TNF), one of several host medi-
ators synthesized by macrophages after exposure to LPS, has been shown to be a
central mediator ofthe shock state in Gram-negative sepsis (2, 3). Infusion ofTNF
into animals produces many of abnormalities characteristic of Escherichia coli/LPS
toxemia, including vascular leakage due to loss of barrier function (2, 4). Vascular
endothelium has been shown tobe adirect target forthe action ofTNF, which causes
modulation ofmany endothelial cell functions, such as coagulant activity and im-
munologic properties (2). Recent studies(5-7) suggest thatthe normal barrierfunc-
tion of the endothelium can also be altered directly by TNF. These considerations
have led us to examine the effect ofTNF on endothelial permeability. The results
indicatethatwithin 1-3 h after exposure toTNF, permeability ofcultured endothelial
monolayers to macromolecular andlowermolecular weight solutesincreasedmarkedly;
this effect wastemporally correlated with alterationsin the cytoskeleton and cell shape,
and the formation of intercellular gaps. Pertussis toxin blocked both the change in
cell shape/cytoskelton and the increase in permeability, indicating that a pertussis
toxin-sensitive G protein critically regulates this TNFinduced response. In con-
trast, otherTNFinduced changes in endothelial cell function, such as perturbation
ofcertaincell surface coagulantproperties, were not affected by pertussistoxin. These
data suggest the presence of more than one TNFdependent signal transduction
pathway within endothelial cells: a pathway involving a pertussis toxin-sensitive G
proteinleadsto increased vascular permeability, whereas, aseparate mechanism un-
derlies the modulation of other cellular properties by TNF.
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MODULATION OF ENDOTHELIAL CELL PERMEABILITY
Materials and Methods
Reagents.
￿
Recombinant human TNF (ti108 U/mg) was generously provided by Dr. P.
Lomedico of Hoffmann-La Roche, Inc. (Nutley, NJ). This preparation was homogeneous
on SDS-PAGE and distinct from lymphotoxin. Bovine protein S, protein C, thrombin, and
antithrombin III were purified by previously described methods (8-11) and protein S was
radioiodinated by the lactoperoxidase method (8,000 cpm/ng) (12). Fatty acid-free bovine
albumin (Sigma Chemical Co., St. Louis, MO) was also radioiodinated by the lactoperoxi-
dase method (5,000 cpm/ng) . After radiolabeling, tracers were de-salted by gel filtration and
subjected to extensive dialysis. Both tracers were >95% precipitable in TCA (15%). Tritiated
inulin (271 mCi/g) and sorbitol (24 Ci/mmol) were purchased from New England Nuclear
(Boston, MA). Monospecific rabbit antiserum to human TNF, generously provided by Dr.
D. Blohm (Knoll, FRG), was used to prepare IgG fraction and coupled to affi-gel 10 (Bio-Rad
Laboratories, Richmond, CA) as described previously (13). Antibody to bovine tissue factor
and purified bovine tissue factor were generously provided by Dr. R. Bach (Mt. Sinai School
of Medicine, New York, NY) (14). Mouse mAb to plakoglobin was obtained from ProGen
(Heidelberg, FRG). Lactate dehydrogenase activity was measured using a kit purchased from
Sigma Chemical Co.
Cell Culture.
￿
Bovine aortic endothelial cells were isolated from calf aortas as described
(15) and were grown in MEM (Gibco Laboratories, Grand Island, NY), supplemented with
penicillin-streptomycin (50 U/ml; 50 t~g/ml), glutamine (1%), and FCS (15%) (HyClone
Laboratories, Logan, UT). Cells were grown in a humidified, 5% C02 atmosphere and were
transferred b trypsinization. For experiments, cells (passages 2-6) from different aortas were
grown to confluence (ti105 cells/cm2) in 35-mm dishes, 24-well, 96-well, or Transwell plates
(6.5-mm polycarbonate membranes, with a pore size of 0.4 Am, mounted on polystyrene
inserts; Costar, Cambridge, MA). For morphologic studies, cells were grown on coverslips
inserted in 35-mm dishes. Cultures were characterized as endothelial by the formation of
cobblestone-like monolayers, contact inhibition at confluence, and the presence of Factor
VIII-related antigen, protein S, and thrombomodulin (15-18). In some studies, endothelial
cultures were preincubated with pertussis toxin (List Biologicals, Campbell, CA) for 18 h
before the start ofan experimental protocol. The range ofpertussis toxin concentrations used
(0.1-10 ng/ml) was based upon earlier studies indicating that this dose range is associated
with progressive ADP ribosylation and inactivation of the endogenous pertussis toxin-sensi-
tive G protein in endothelial cultures (19). At a concentration of 10 ng/ml of pertussis toxin,
>98,70 ofthe endogenous pertussis toxin-sensitive G protein in the culture is ADP ribosylated.
Moreover, higher concentrations ofpertussis toxin (100 ng/ml) appeared to have a direct toxic
effect on the cultures, perhaps due to the known action of high concentrations of the toxin
to directly activate cells (20), and were not used.
Permeability Studies.
￿
Confluent monolayers (5-6 d after plating) in Transwell inserts were
washed with Earle's balanced salt solution (0.5 ml), and either MEM containing fatty acid-free
BSA (1% ; Sigma Chemical Co.) or medium containing FCS (5%) was added to each com-
partment (to avoid an oncotic gradient). Final volumes present in the inner and outer (corre-
sponding to upper and lower, respectively) chambers were adjusted to yield no hydrostatic
gradient across the monolayer. Radiolabeled markers (albumin, inulin, or sorbitol) were then
added in trace concentrations (150 ng/ml, 3 kg/ml, and 38 ng/ml, respectively) to the upper
chamber. TNF or heat-treated TNF (and other agents such as cycloheximide or actinomycin
D) was added simultaneously with the tracers unless indicated otherwise. For assays, the
chambers were incubated at 37°C in a 5% C02 atmosphere with continuous agitation, and
samples (0.005 ml) were withdrawn at the indicated times. The volume in the chambers was
not changed significantly (<5 17o) as a result of sampling ofwells during the experiment. Trans-
port of tracers from the inner to outer chamber, i.e., across the endothelial monolayer, was
determined by dividing radioactivity in the outer well by radioactivity in the inner well (mea-
sured from duplicate 0.005-ml samples from each well). Wells were also sampled within 5
min of tracer addition to establish a to background level, and monolayers displaying evidence
of leakage were discarded. Since experiments with "5I-albumin were carried out in the pres-
ence ofa large excess of unlabeled ligand, the observed passage oftracer across the monolayer
was not due to a receptor-mediated process.BRETT ET AL.
￿
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Immunocytology.
￿
Cell monolayers grown on coverslips were fixed briefly (1-2 min) in PBS,
pH 7.2, containing 3.5% formalin and 0.1% NP-40, then in 3.5% paraformaldehyde without
NP-40 for an additional 5 min and washed in PBS. For visualization of F-actin, coverslips
were incubated with rhodamine-conjugated phalloidin (MolecularProbes,Junction City, OR)
for 30-45 min, washed in PBS, and mounted in Gelvatol containing 1 mg/ml p-phenyl-
enediamine. Mounted coverslips were examined in a microscope (Dialux 20; E. Lietz, Inc.,
Wetzlar, FRG) and recorded on Kodak Tri-X film. The protocol for visualization ofplakoglobin
was similar to that described previously for protein S (17).
EM.
￿
Monolayers grown on glass coverslips were fixed for scanning EM in cacodylate
buffer (0.1 M, pH 7.2) containing glutaraldehyde (2.5%) and sucrose (2%) for 45 min, and
then washed three times in buffer followed by post-fixation in buffer containing osmium
tetroxide (2%). Fixed monolayers were dehydrated in ethanol, transferred to Pel-Dry (Ted
Pella Inc., Redding, CA), and dried by sublimation in a fume hood. Dried monolayers were
coated with gold palladium and viewed in a scanning electron microscope (T-300, Joel, Pea-
body, MA).
Assays ofEndothelial Cell Coagulant Properties.
￿
The study ofprotein S released by endothelium
was carried out by a previously described method (17, 19). In brief, confluent endothelial
monolayers (9.6 cm2) were washed four times over a period of 1 h at 37°C. This resulted
in dissociation of cell surface protein S before the start of an experiment designed to detect
release of intracellular protein S from endothelium in response to TNF After washing, 1 ml
of MEM containing HEPES (10 nM; pH 7.4) and BSA (5 mg/ml) were added in the presence
or absence ofmediators. Aliquots of culture supernatant were obtained at the indicated times
and assayed for protein S antigen as described previously (19). When law levels of protein
S antigen were detected in samples, assays were repeated after 10-fold concentration.
Induction ofendothelial cell tissue factor activity was studied by incubating endothelium
with TNF (0.5 nM) in MEM containing 1% FCS. Tissue factor activity of endothelial cells
was then measured using a coagulant assay after8 h, as described previously (21). The specificity
of this assay for measurement of endothelial cell procoagulant activity induced by TNF was
confirmed by studies using rabbit antibovine tissue factor IgG (14). Preincubation of cells
with this IgG (10 Ecg/ml) for 1 h at 37°C before carrying out the tissue factor assay blocked
the procoagulant activity observed in TNFstimulated endothelium. The amount oftissue
factor activity present in samples was determined by comparison of the clotting time with
a standard curve constructed using the same tissue factor assay and purified bovine tissue
factor (14).
TNFinduced suppression of endothelial cell thrombomodulin was studied by incubating
confluent monolayers (0.32 cm2) with TNF (0.5 nM) for 8 h at 37°C. Thrombomodulin ac-
tivity was then assessed by measuring thrombin-mediated protein C activation over the en-
dothelial cell monolayers as previously described (22). In brief, samples were incubated with
thrombin (0.2 U/ml) and protein C (90 hg/ml) for 30 min at 37°C. Antithrombin III (0.2
mg/ml) and heparin (1 U/ml) were added next, and then hydrolysis of the chromogenic sub-
strate Lys-Pro-Arg-p-nitroanilide (Spectrozyme, American Diagnostica, NY, NY) was moni-
tored at 405 run. The amount ofactivated protein C formed was determined by comparison
with a standard curve made with known amounts of activated protein C.
Results
Cell Shape and Cytoskeleton.
￿
Normal endothelium forms a contiguous monolayer
of closely apposed polygonal cells, each of which has a prominent circumferential,
peripheral band of actin microfilaments and a more variable display of thin, ran-
domly oriented stress fibers (Fig. 1 A). Cells are closely apposed about their entire
circumference, being secured in place byjunctional complexes ofthe plasmalemma,
chiefly, actin microfilament-associated maculae and zonulae adherents, character-
ized by their content of plakoglogin (23) (Fig. 1 F). Within 30-60 min of exposure
to TNF (5 nM) (the latter concentration of TNF was used in this study since, as
described below, it results in maximal TNFinduced modulation of endothelial per-1980
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F[GURE 1 .
￿
TNRinduced perturbation of cell shape/cytoskeleton. Monolayers of cultured en-
dothelial cells were incubated in the presence or absence ofTNF for the indicated times . The
actin-based cytoskeleton was then visualized by rhodamine phalloidin staining (A-C, E) and
plakoglobin distribution was displayed with amousemAbvisualized with FITC-conjugated goat
anti-mouse antibody (F-G) . Cell shape was also assessed by scanning EM (D) . (A) Control
monolayer; (B) cultures exposed to TNF (5 nM) for 90 min . Arrows represent areas of lateral
cell margin retraction ; (C) cultures exposed toTNF (5nM) for 24 h; (D) scanning electron micro-BRETT ET AL.
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meability), peripheral actin bands become indistinct and disappear, while at the same
time, the central stress fibers in most of the cells become transiently more numerous
and prominent, and subsequently condense, shorten, and appear to fuse. By 60-90 min
of treatment with TNF, these stress fibers have contracted into densemicrofilamentous
(actin) masses. Cytoskeletal changes occur concomitant with the onset of mutual
cell retraction, whichresults in theformation ofintercellular gaps exposing the under-
lyingmatrix (Fig. 1 B). These processes continue slowly, and at latertimes (4-24 h),
gaps between theretracted cells are larger and more numerous (Fig. 1 C). Theretracted
cells remain apposed and adherent over wide sectors, in which the arrangement of
adhaerens junctions, identified in Fig. 1 G by their plakoglobin, appear relatively
intact. However, the immunocytochemically detected plakoglobin of many sectors
of membrane bordering the gaps becomes attenuated and may disappear (Fig. 1
G). All cellular margins are sharply outlined by actin of the plasma membrane
cytoskeleton, which appears to become augmented at later times ofexposure to TNF
(Fig. 1 C) . The intercellular gaps are well shown in the scanning electron micro-
scope, which also reveals many protrusions on the upper (abbasal) surfaces of TNF-
treated cells (Fig. 1 D), membrane-bound excrescences that are stuffed with
microfilamentous actin. Throughout these events, the microtubule array appears
unaffected, save for apparently passive displacements.
TNF-induced perturbation of endothelial ultrastructural characteristics is not a
consequence of nonspecific toxicity; there was neither significant release of LDH
into the medium, nor permeability to trypan blue, nor detachment of cells from
the growth surface. Furthermore, these perturbations of endothelial cell shape and
cytoskeletal integrity are reversible (Fig. 1 E). This was established by exposing cul-
tures to TNF for 4 h, washing, and transferring the cultures to fresh medium . At
36 h, the cells had re-established a contiguous monolayer with few evident gaps,
and the cytoskeleton displayed prominent marginal bands with few central stress
fibers (compare Fig. 1, E and A).
BarrierFunction.
￿
The actions of TNF to induce cytoskeletal rearrangements and
cell retraction couldlead to changes in endothelial barrierfunction. To test this directly,
bovine aortic endothelial cells were cultured on microporous (0.4-p.m) polycarbonate
membranes. Monolayers formed on these membranes are capable of restricting
diffusional passage of molecular markers as compared with membranes alone or
confluent monolayers ofbovine fibroblasts (Fig. 2). Incubation of endothelium with
TNF (100 ng/ml; -5 nM) led to a steady increase in the passage of tracer molecules
across themonolayers (Fig. 3, A-C). Tracer solutes ofarange ofmolecular weights/sizes
were used (1251-albumin, M r ￿67000; [3H]inulin, M r =5000; [3H]sorbitol, Mr =500)
in orderto better characterize thenature of the diffusional defect. The TNRinduced
increase in permeability to sorbitol wasdetectable by 60 min, whereas the enhanced
permeability to larger molecular weight solutes (albumin and inulin)wasdetectable
graph of cells exposed to TNF (5 nM) for 4 h; (E) cultures exposed to TNF (5 nM) for 4 h,
rinsed, and then maintained in fresh medium for 36 h; (F) localization of plakoglobin at the
lateral margins (arrows) of confluent control endothelial cell monolayers; (G) distribution of
plakoglobin afterTNF(5 nM)for4h. Large sectorsof the lateral cell margins (arrows) maintain
a relatively intact plakoglobin distribution. Details of methods are described in the text. A-C
and E-G, x 600; D, x 6,500.1982
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FIGURE 2 .
￿
Barrier function of monolayers grown on polycarbonate
membranes . Membranes alone (O) or with confluent monolayers of
endothelial cells (EC) or bovine fibroblasts (F) were incubated with
[3H]sorbitol, and transfer oftracer across the membrane was deter-
mined at the indicated times as described in the text . Mean ± SD
is shown .
at 120 min (Fig . 3A-C) . Permeability to allthree tracers continued to increase steadily
and progressively up to 4-8 h, ultimately attaining rates 1 .5-2 times greater than
the basal control rate. Thechanges in permeability induced by TNF were sustained
for up to 24 h thereafter (data not shown) .
The effect of TNF on monolayer permeability was concentration dependent .
Monolayer permeability to all three tracers was half-maximal at a TNF concentra-
tion of-0 .5 nM and reached an apparent maximum by 5 nM (Fig . 3, D-F) . This
dose dependence roughly parallels the binding parameters previously reported for
occupancy of TNF receptors on endothelium (13) and other cell types (24-29) in
which the affinity of radioiodinated TNF for the cell surface was -0.2-0.6 nM .
The effects of TNF on endothelial barrier function are specific and not due to
the presence of any contaminant potentially present in the preparation (LPS, for
example, has been shown to be directly toxic to bovine endothelial cells [30]) . A
TNF stock solution (20 nM) depleted ofTNF by chromatography on an affigel 10
FIGURE 3 .
￿
Effect of TNF on endothelial cell
monolayer permeability to 12'1-albumin, [3H]in-
ulin, and [3H]sorbitol . (A-C) Time Course, cul-
tures were incubated either with 1251-albumin
(A), [3H]inulin (B), or [3H]sorbitol (C) for the in-
dicated times in the presence (*) or absence (")
ofTNF(5 nM), and transfer oftracer across the
monolayer was determined as described . Addi-
tional controls included inA: (Ab) theTNF prep-
aration was pre-absorbed with a column of im-
mobilized antiTNF IgG; and (Heat) TNF was
heat inactivated before use (see text for details) .
(D-F)Dose response : monolayers were incubated
with 1251-albumin (D), [3H]inulin (E), or 13H1
sorbitol (F) in the presence ofvariousTNF con-
centrations (0.05-10nM) for4hand barrierfunc-
tion was determined . Control (darkened bar) denotes
monolayers to which no TNF was added . The
mean ± SD is shown.BRETT ET AL .
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column with immobilized IgG from a monospecific anti-human TNF antiserum
(13) did not induce increased albumin permeability across monolayers (Fig. 3 A) .
In contrast, TNF solutions passed through a similar column with nonimmuneIgG-
altered permeability of the monolayer to albumin in a manner identical to native
TNF . Furthermore, heat-treated TNF, which is biologically inactive (31), did not
alter permeability. Taken together, these data indicate that TNF is the active species
promoting diffusion, not contaminating endotoxin or other substances .
Since the half-life ofTNF in the circulation is measured in minutes (32), we won-
dered whether short exposures toTNF lead to more sustained alterations in endothelial
barrier function . To address this question, endothelium was exposed toTNF (1 nM)
for 15 min at 37°C, extensively washed to remove unbound material, and perme-
ability was assessed at 4h. Monolayers treated in this fashion displayed increased
permeability to 1251-albumin and could not be distinguished from monolayers ex-
posed to TNF continuously for 4 h (Fig . 4 A) . Similar results were observed with
inulin and sorbitol . These studies indicate that TNF binds to its endothelial cell
receptors rapidly and initiates a series of events that lead to increased permeability
of monolayers . Continued presence of cytokine in the supernatant is not required
to maintain theresponse. Although only briefexposure toTNFinduces the endothelial
cell response, recovery of barrier function required considerable time (Fig . 4 B) .
After exposure to TNF for 4 h, an additional 36 h was required for permeability
to reach pretreatment levels .
To examine whether the effect of TNF to enhance endothelial permeability re-
quired de novo protein synthesis, endothelial monolayers were exposed to TNF in
the presence of inhibitors of protein andRNA synthesis (Table I) . Neither cyclohex-
imide (10 Fig/ml) nor actinomycin D (1 gg/ml) impaired the actions of TNF to en-
hance monolayer permeability. Higher concentrations ofthese inhibitors were directly
cytotoxic, precluding assessment of permeability changes . However, the concentra-
tions of inhibitors tested did result in >90% decrease in total protein (based on
[3H]leucine incorporation) and RNA (based on [3H]uridine incorporation) syn-
thesis . These results suggest that the effect of TNF to increase albumin diffusion
across endothelium is not dependent upon de novo protein synthesis and contrasts
with other cellular effects of TNF that do require the biosynthetic apparatus .
Coagulant Properties.
￿
Changes in endothelial permeability can result in perturba-
tion of the coagulation mechanism . On the one hand, plasma constituents, such
FIGURE 4 .
￿
TNF-mediated perturbation of endothelial cell bar-
rier function: the effect of brief exposure of cultures to TNF and
recovery. (A) Effect of briefexposure of monolayers to TNF . Cul-
tures were either incubated withTNF (5nM) for 15 min, followed
by 10 washes, and placed in freshmedium for4h(M or medium
containingTNF for4h(TNF) . Control cultures were not exposed
to TNF (0) . 125I-albumin passage across monolayers was deter-
mined by incubating tracer with cultures for 2 h . (B) Recovery.
Cultures were exposed to TNF (5 nM) for 4 h (TNF) and then
washed (four times over 30 min) and incubated with freshmedium
for 36 h(M . Controls (0) were not exposed toTNF . Permeability
was determined at the indicated times by assessing passage of
115j
albumin across the monolayer during a 4-h incubation after the
indicated pretreatment . Details of experimental procedure are de-
scribed in the text . The mean t SD is shown .1984
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TABLE I
Effect of Cycloheximide and Actinomycin D on TNF-induced
Modulation of Endothelial Cell Barrier Function
Condition
￿
Percent 1251-albumin transfer
Control (no addition)
￿
4 .1 ± 0.2
Cycloheximide alone
￿
4 .2 ± 0.2
Actinomycin D alone
￿
4 .7 ± 0.2
TNF
￿
6 .9 +_ 0.6
TNF + cycloheximide
￿
7 .1 ± 0 .7
TNF + actinomycin D
￿
7 .0 ± 0.6
Endothelial cell monolayers were incubated for 4 h in either normal medium
(control), medium supplemented with cycloheximide (10 Wg/ml) alone, actinomy-
cin D (1 .0 ttg/ml) alone, TNF (5 nM) alone, TNF (I nM) and cycloheximide
(10 fag/ml), or TNF (I nM) and actinomycin D (1 tag/ml) . Passage of 125I-
albumin across monolayers was assessed by adding tracer to the chamber above
the monolayers at the time TNF/drugs were added over the 4-h period . The mean
+ SD is shown .
as clotting factors, are lost from the intravascular space . Specifically, protein S, an
anticoagulant cofactor that functions effectively on the surface ofquiescent endothelium
(33), was observed to pass throughTNFtreated monolayers (ina manner analogous
to that observed in studies with radioiodinated albumin described above) . Loss of
protein S from the vascular lumen could potentially lead to attenuation of an in-
travascular antithrombotic mechanism . Since protein S is synthesized and stored
in endothelium (17), one possible compensatory mechanism to counterbalance loss
of plasma protein S could involve TNFstimulated release of protein S (6) . Incuba-
tion ofTNF with monolayers did lead to release of protein S into the supernatant
in a time- and dose-dependent manner. The effect ofTNF on endothelial cell pro-
tein S release was fully expressed by 40 min (FIg . 5 A) ; a half-maximal effect oc-
curred at aconcentration of -100 pM (Fig . 5 B) . In a previous study we found that
release ofendothelial cell protein S in response to norepinephrine could be blocked
by pertussis toxin . Those results led us to examine whether pertussis toxin had a
FIGURE 5 .
￿
Release of protein S from
endothelial cells : effect ofTNF and per-
tussis toxin . (A) Time course. After
removal of cell surface protein S, en-
dothelial monolayers were incubated
with TNF (1 nM) and aliquots of su-
pernatant were removed at the indi-
cated times and assayed for protein S
antigen . (B) Dose response . Endothe-
lium was incubated with varying con
centrations ofTNF (10-1,000 pM) for 50 min and samples of culture medium were assayed for protein
S antigen . (C) Effect ofpertussis toxin. Endothelial cell monolayers were preincubated in complete medium
alone or in the presence of pertussis toxin (10 ng/ml) for 18 h at 37°C . Then cultures were exposed
to TNF (200 pM) or fresh culture medium alone and supernatants were assayed for protein S antigen
after 50 min. The mean of triplicates is shown and SD was <15% in each case. Details ofexperimental
procedures are described in the text . Control, cultures exposed to culture medium alone ; TNF, cultures
preincubated in normal growth medium and then exposed toTNF ; PT, cultures preincubated with per-
tussis toxin and then incubated in normal medium ; PT/TNF, cultures preincubated with pertussis toxin
and then exposed to TNF.BRETT ET AL. 1985
similar effect on TNFinduced release of protein S . Preincubation of cultures for
18 h with pertussis toxin (10 ng/ml), a protocol previously found to be associated
with >98% ADP ribosylation and inactivation of the endogenous pertussis toxin-
sensitiveG protein in endothelial cultures (19), markedly attenuated TNFinduced
release of protein S (Fig. 5 C) .
Role ofthe Pertussis Toxin-sensitive G Protein.
￿
Studies demonstrating that pertussis
toxin inhibits the action of TNF to release endothelial cell protein S (19) support
a role for a pertussis toxin-sensitiveG protein in signal transduction at the TNF
receptor. We examined whether other effects ofTNF on endothelial cell physiology
are similarly dependent upon a pertussis toxin-sensitive intracellular transduction
mechanism . Cultures were preincubated for 24 h with a range of pertussis toxin
concentrations previously shown to induce partial (0.1-1 ng/ml) or complete (10 ng/ml)
ADP ribosylation and inactivation of the endogenous pertussis toxin-sensitive G
protein (19) . These studies indicated that pertussis toxin inhibits the effect ofTNF
to augment passage of [3H]inulin across endothelial monolayers in a dose-dependent
fashion (Fig. 6 A) . Moreover, the dose-response relationship for the effect of per-
tussis toxin to inhibit this TNF response and to ADP ribosylate the endogenous
FIGURE 6.
￿
Effect of pertussis toxin on TNF-induced perturba-
tion ofendothelial cell barrier function and cytoskeleton/cell shape .
Cultures were preincubated for 18 h with growth medium alone
or medium supplemented with pertussis toxin at the indicated con-
centration (0.1-10.0 ng/ml), after which they were placed in medium
alone (control), medium containing TNF (TNF), pertussis toxin
(P7'), or pertussis toxin and TNF (PT/TNF) . Passage of tracers,
as indicated ([ 3H]inulin, A; 1251-albumin, B; [3H]sorbitol, C),
through monolayers, was measured over 4 h starting after the 18-h
preincubation period . (B and C) The concentrations ofTNFand
pertussis toxin were 5 nM and 10 ng/ml, respectively . The mean
± SD is shown . Details ofexperimental procedure are described
in the text . Control, cultures exposed to normal growth medium
alone ; TNF, cultures preincubated in normal growth medium and
then exposed toTNF for4h ; PT, cultures preincubated with per-
tussis toxinandthen incubated in normal culturemedium ; PT/TNF,
cultures preincubated with pertussis toxin and then exposed toTNF
(5 nM) . (D) Cytoskeleton/cell shape. Rhodamine phalloidin staining
of the actin-based cytoskeleton after exposure of cultures to per-
tossis toxin (10 ng/ml) and TNF (5 nM) as describedabove. This
micrograph should be compared with Fig. 1, A and B. (x 600) .1986
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FIGURE 7 .
￿
Effect of pertussis toxin on TNF-
induced modulation ofendothelial cell coagulant
properties: induction oftissue factor (A)and sup-
pression of thrombomodulin (B) . Cultures were
preincubated for 18 h with either complete medi-
um or medium supplemented with pertussis toxin
(10 ng/ml) . Then cultures were placed in fresh
medium with eitherTNF (0 .5 nM) or no further
addition was made. Assays of tissue factor and
thrombomodulin activity were made after an additional 8 h of incubation . Data is shown as percent
maximal tissue factor induction(maximal tissue factor induction is that observed with TNF alone and
corresponds to 38 fmol/106 cells) and percent maximal protein C activation (maximal protein C acti-
vation is that observed on endothelium incubated with normal medium andcorresponds to 25 14g/ml/
30 min). The mean t SD is shown and details of experimental procedure are described in the text .
control, cultures exposed to normal growth medium alone ; TNF, cultures preincubated in normal growth
medium and then exposed toTNF; PT, cultures preincubated with pertussis toxin andthen incubated
in normal culture medium; PT/TNF, cultures preincubated with pertussis toxin and then incubated
with TNF .
G protein correlated highly, providing strong evidence for a role for a pertussis
toxin-sensitiveG protein in this TNF response . Pertussis toxin also blocked the in-
crease in endothelial permeability to radiolabeled albumin and sorbitol induced by
TNF (Fig . 6, B-C) . Consistent with these results, cytokine-mediated perturbations
of the actin-based cytoskeleton and cell shapewere also inhibited by pertussis toxin,
albeit not completely (Fig . 6 D) . These results constitute strong evidence that these
acute changes in endothelial cell physiology inducedby TNF (enhanced permeability
and release of protein S) are mediated by a pertussis toxin-sensitive G protein . In
contrast, when other TNFinduced perturbations of endothelial cell function were
examined in a similar fashion, a different result was observed (Fig . 7) . The effect
of TNF to promote the synthesis and expression of tissue factor procoagulant ac-
tivity (22, 34) is not mediated by pertussis toxin (Fig . 7A). Similarly, pertussis toxin
did not alter TNFmediated suppression of endothelial cell thrombomodulin (Fig.
7 B) . Taken together, these results suggest that at least two separate transduction
pathways are utilized by TNF that can be distinguished by their sensitivities to per-
tussis toxin .
Discussion
The results presented herein demonstratethat TNF can increase the permeability
ofcultured bovine aortic endothelial cell monolayers to macromolecules and smaller
solutes . Although endothelial cell monolayers that form on the artificial surfaceused
in these studiesandby otherlaboratories (35-41) are more permeablethan the phys-
iologic endothelial monolayer within the vascular wall, they have provided a useful
model to examinecomponents ofthe response toTNF As a result, ourdata indicate
that the loss of intravascular solutes in the septic state may result from the direct
action ofTNF on endothelium to perturb itsnormal barrier function . Future studies
that evaluate these in vitro findings within the context ofthe diverse biological effects
ofTNF in an in vivo model ultimately will be necessary to interpret the role of this
TNF-induced perturbation in the pathogenesis of endotoxic shock .
The observations resultingfrom our studies indicate that TNFinduces a progres-
sive and marked change in disposition ofthe actin-based cytoskeleton that is accom-
panied by cell retraction (Fig . 1) . Theseperturbations appear to result in the forma-BRETT ET AL.
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tion of inter-endothelial cell spaces (Fig. 1). Although a contractile event may be
inferred, these observations do not yet permit us to assign a causal relationship be-
tween these coincident events. It is apparent, however, that the gaps between cells
resulting from cell retraction are a route for passage of macromolecules across the
monolayer. In support of the hypothesis that retraction of lateral cell margins, with
its resultant enhanced permeability, may be brought about by an active cytoskeletal
event, inhibition ofthe TNFinduced perturbations of cytoskeletal assembly by per-
tussis toxinis associated with attenuationoftheaction ofTNFto augmentendothelial
permeability. While these observations do not rule out thepossibility that areceptor-
mediated transcytotic pathway results in at least a component of the enhanced per-
meability of endothelial monolayers in response to TNF (42-44), they do indicate
that the para-cellular pathway via inter-endothelial cell gaps is the predominant av-
enue of solute exit.
Although these structural changes in endothelium after exposure to TNF were
observed with a variety of bovine aortic endothelial cell cultures (from over adozen
animals and cells from passages 2-20), the cellular response may well be different
when endothelium from different vascular beds are examined. Forexample, theshape
and cytoskeletal changes depicted in human umbilical vein endothelial cells after
longer (72-96 h) exposure to lower concentrations of TNF (45) differ from those
shown in Fig. 1; this difference could be related to conditions of dosage, or it might
be due to site or species differences. Experiments with multiple concentrations of
TNF usingendothelial cells derivedfrom severallocations (and in different species)
will be required to resolve this issue.
Retraction of endothelial cells with the formation of gaps in the monolayer has
been observed in response to vasoactive mediators such as histamine and serotonin
(35, 46-50). The effect ofhistamine to activate endothelial inositol phospholipid me-
tabolism and thereby mobilize intracellular calcium through an Hi receptor-depen-
dent mechanism is believed to underlie this physiologic response (49, 50). Despite
certain similarities of the endothelial cell response to histamine and TNF, in opening
aparacellular pathwayoftransudation, preliminary studiesin ourlaboratory do not
provide any evidence that TNF activates a similar rapid cellular response mecha-
nism. Mechanisms ofintracellular signal transduction after stimulationof cells with
TNF have been difficult to identify. By focussingon earlyperturbationsofendothelial
cell physiology, such as protein S release andalteration in the actin-based cytoskeleton,
we have found that one component of the endothelial cell response to TNF involves
apertussis toxin-sensitive regulatory G protein. Clark et al. (7) have proposed that
the very rapid (5-10 min) retraction and increase in permeability of endothelial cells
of the CPAE cell line induced by TNF is coupled by a pertussis toxin-sensitive de-
pendent G protein and results from enhanced phospholipase A2 activity and eicosa-
noid release. Furthermore, they found that cell shape and permeability change could
be prevented by pretreatment with the inhibitor of eicosanoid synthesis BW755c,
and by inhibitors of protein synthesis. In our hands, exposure of endothelium to
TNF did not lead to the release of [3H]arachidonic acid metabolites and the phos-
pholipase A2-activating protein inhibitor BW755c had no protective effect on TNF
inducedperturbation of cytoskeleton/cell shape or barrier function over a wide range
of concentrations and incubation times (data not shown). In addition, inhibitors
of protein biosynthesis (which would have prevented synthesis of phospholipase1988
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A2-activating protein) had no effect on modulation of barrier function (Table I).
The reason for the differences between our observations and those ofClark et al.
(7)are notclear, however, it maybethat theiruse ofsuper-saturating concentrations
ofTNF (1,700 ng/ml) and ofthe CPAE cell line, as compared with our lower doses
ofTNF (doses that correlate with receptor occupancy) and use ofbovine aortic en-
dothelial cells passages 2-6, might explain why different mechanisms appear to be
involved in the cellular response to TNF. On the other hand, our studies confirm
and extend recent evidence for a critical role for a pertussis toxin-sensitive G pro-
tein in at least some biological responses to TNF (51).
In contrast to the protective effect ofpertussistoxin on monolayerbarrier function
(Fig. 6), TNFinduced enhancement ofendothelial cell tissue factor, which involves
denovo transcription and translation (22, 34), andTNFinduced suppression ofthrom-
bomodulin activity, which involves adecline in thelevel ofthrombomodulin antigen
(52), were not affected by pertussis toxin (Fig. 7). These data suggest a model in
which certain rapid cellular responses toTNFare mediated by apertussis toxin-sensi-
tive G protein, whereas other slower perturbations ofcellular physiology, including
some that involve regulation at the transcriptional/translational level, are brought
about by recruitment of different intracellular mechanisms.
Summary
Endothelium is an important target of tumor necrosis factor/cachectin (TNF),
a central mediator of the host response in endotoxemia and Gram-negative sepsis.
In this report, TNF is shownto increasethepermeability ofendothelial cell monolayers
to macromolecules and lower molecular weight solutes by a mechanism involving
a pertussis toxin-sensitive regulatory Gprotein. Within 1-3 h ofexposure to TNF
(5 nM), changes incellshape/cytoskeleton occurred thatled todisruption ofmonolayer
continuity with the formation ofintercellular gaps. Correlated with these structural
changes was an increase in endothelial permeability to macromolecular and lower
molecular weight tracers; time-dependent, reversible increases in passage ofthese
tracers, evident by 1-3 h, were observed afteraddition ofTNFto cultures. Perturba-
tion of barrier function by TNF also depended on the dose of TNF added being
half-maximal by -0.4 nM. Only a briefexposure (15 min) ofTNF to endothelium
was required to induce an increase in permeability, and this was not prevented by
the presence ofcycloheximide or actinomycin D. Preincubation ofmonolayers with
pertussis toxin blocked in parallel TNFinduced increased passage of solutes and
cell shape/cytoskeletal perturbation, indicating the close correlation between these
changes in endothelial cell function. In contrast, pertussis toxin did not alter TNF
induced modulation oftwo endothelial cell coagulant properties. These data pro-
vide evidence for two intracellularpathways ofTNF action that are distinguishable
by pertussis toxin and provide insight into a mechanism underlying loss of solute
from the intravascular space mediated byTNF: alteration in endothelialcell barrier
function.
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